The increasing availability of effective #HIV treatments within low and middle-income countries has produced encouraging signs of progress, yet there is more work to be done to fight the epidemic. Our VP of Access Operations and Emerging Markets, Papa Salif Sow, expands on this global-scale effort to improve access in this month’s issue of New Scientist: http://glassdoor.com/slink.htm?key=vQwXR.
People living with HIV can now live longer, fuller lives thanks to a series of biomedical breakthroughs and the dedication of thousands of researchers around the world. Learn more about 30 years of progress in HIV treatment from our Medical Director, Peter Borg, in the most recent issue of New Scientist: http://glassdoor.com/slink.htm?key=vQNTR.
More than 12,000 people in Alabama were living with HIV in 2014. Douglas Brooks, our Senior Director for Community Engagement, and Nic Carlisle of the Southern AIDS Coalition highlight a new partnership with the Southern HIV/AIDS Strategy Initiative at Duke University as part of the Gilead COMPASS Initiative™ Corporate Giving Program which aims to combat the HIV/AIDS epidemic in Birmingham, AL and across the Southern U.S. Read more at http://glassdoor.com/slink.htm?key=vQsIf: http://glassdoor.com/slink.htm?key=vQsI6.
We at Gilead Sciences support our colleagues at Kite Pharma and their dedication to driving cancer research that has the potential to improve the lives of people living with the disease around the world. #WorldCancerDay
CAR T cell immunotherapy named the Advance of the Year in annual ASCO report. We’re proud to play a role in advancing cell therapy: http://glassdoor.com/slink.htm?key=vQssQ
We’re proud to join more than 500 organizations in support of the U=U Consensus Statement. Learn more about the U=U campaign and the full Consensus Statement: http://glassdoor.com/slink.htm?key=vQU3B.
Throughout 2018 we will be sharing a quick glimpse into our working lives here at Gilead.
Meet Lauryn from the Regulatory Affairs team in Foster City http://glassdoor.com/slink.htm?key=vQUsV . #gileadlife
Gilead's subsidiary Kite announces clinical collaboration with Pfizer to evaluate investigational treatment combination in large B-cell lymphoma. Find out more: http://glassdoor.com/slink.htm?key=vQURO
Throughout 2018 we will sharing a quick glimpse into our working lives here at Gilead.
Please meet Ligia from the Biometrics team based in Foster City. #gileadlife http://glassdoor.com/slink.htm?key=vQgK0
The Medical Affairs team at Gilead is a team of highly skilled medical and non-medical professionals commitment to helping patients maximize the benefits they receive from our therapeutics through the ethical generation, education, differentiation and communication of scientific information.
If you have a clinical background and wish to support a worldwide group of patients in a fast paced, career oriented environment, please get in touch. http://glassdoor.com/slink.htm?key=vQgDE